{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:02:05Z","timestamp":1762542125919},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1097\/mph.0b013e31827e4c28","type":"journal-article","created":{"date-parts":[[2013,1,18]],"date-time":"2013-01-18T08:11:12Z","timestamp":1358496672000},"page":"156-161","source":"Crossref","is-referenced-by-count":15,"title":["A Child With Gemcitabine-induced Severe Radiation Recall Myositis Resulting in a Compartment Syndrome"],"prefix":"10.1097","volume":"35","author":[{"given":"Mark A.","family":"Eckardt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrienne","family":"Bean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael T.","family":"Selch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noah","family":"Federman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-16-20210227","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1148\/73.2.175","article-title":"Potentiation of x-ray effects by actinomycin D.","volume":"73","author":"DAngio","year":"1959","journal-title":"Radiology"},{"key":"R2-16-20210227","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1002\/cncr.20229","article-title":"Gemcitabine-related radiation recall preferentially involves internal tissue and organs.","volume":"100","author":"Friedlander","year":"2004","journal-title":"Cancer"},{"key":"R3-16-20210227","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.7863\/jum.2010.29.10.1499","article-title":"Sonographic features of pectoralis muscle necrosis secondary to gemcitabine-induced radiation recall: case report and review of current literature.","volume":"29","author":"ORegan","year":"2010","journal-title":"J Ultrasound Med"},{"key":"R4-16-20210227","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1080\/10428190500158649","article-title":"Gemcitabine-induced pericardial effusion and tamponade after unblocked cardiac irradiation.","volume":"46","author":"Vogl","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"R5-16-20210227","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1086\/520684","article-title":"Gemcitabine-related pseudocellulitis: report of 2 cases and review of the literature.","volume":"45","author":"Tan","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R6-16-20210227","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1634\/theoncologist.2009-0090","article-title":"Radiation recall with anticancer agents.","volume":"15","author":"Burris","year":"2010","journal-title":"Oncologist"},{"key":"R7-16-20210227","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1200\/JCO.2008.20.3778","article-title":"Phase II study of weekly gemcitabine and vinorelbine for children with recurrent or refractory Hodgkins disease: a childrens oncology group report.","volume":"27","author":"Cole","year":"2009","journal-title":"J Clin Oncol"},{"key":"R8-16-20210227","doi-asserted-by":"crossref","first-page":"S445","DOI":"10.1097\/CCM.0b013e3181ec5d09","article-title":"Compartment syndromes from head to toe.","volume":"38","author":"Balogh","year":"2010","journal-title":"Crit Care Med"},{"key":"R9-16-20210227","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.jpedsurg.2004.12.007","article-title":"Compartment syndrome in children and adolescents.","volume":"40","author":"Grottkau","year":"2005","journal-title":"J Pediatr Surg"},{"key":"R10-16-20210227","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1200\/JCO.1994.12.8.1535","article-title":"Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study.","volume":"12","author":"Abratt","year":"1994","journal-title":"J Clin Oncol"},{"key":"R11-16-20210227","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1023\/A:1008365221440","article-title":"Radiation myositis.","volume":"10","author":"Welsh","year":"1999","journal-title":"Ann Oncol"},{"key":"R12-16-20210227","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1200\/JCO.2000.18.3.693","article-title":"Side effects of chemotherapy. Case 1. Radiation recall dermatitis from gemcitabine.","volume":"18","author":"Burstein","year":"2000","journal-title":"J Clin Oncol"},{"key":"R13-16-20210227","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1200\/JCO.2000.18.3.695","article-title":"Side effects of chemotherapy. Case 2. Radiation recall reaction induced by gemcitabine.","volume":"18","author":"Castellano","year":"2000","journal-title":"J Clin Oncol"},{"key":"R14-16-20210227","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1023\/A:1008353224251","article-title":"Radiation myositis: the possible role of gemcitabine.","volume":"11","author":"Ganem","year":"2000","journal-title":"Ann Oncol"},{"key":"R15-16-20210227","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/S0167-8140(00)80034-1","article-title":"35 radiation recall dermatitis from gemcitabine. A new toxic effect in 3 patients.","volume":"57","author":"Sole Monne","year":"2000","journal-title":"Radiother Oncol"},{"key":"R16-16-20210227","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1177\/030089160108700614","article-title":"Gemcitabine-induced radiation recall dermatitis: case report.","volume":"87","author":"Bar-Sela","year":"2001","journal-title":"Tumori"},{"key":"R17-16-20210227","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0169-5002(01)00194-5","article-title":"Radiation recall reaction following gemcitabine.","volume":"33","author":"Fogarty","year":"2001","journal-title":"Lung Cancer"},{"key":"R18-16-20210227","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0360-3016(02)02773-6","article-title":"Gemcitabine-induced radiation recall.","volume":"53","author":"Jeter","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R19-16-20210227","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0090-8258(03)00404-9","article-title":"Gemcitabine-induced radiation recall dermatitis following whole pelvic radiation therapy.","volume":"91","author":"Schwartz","year":"2003","journal-title":"Gynecol Oncol"},{"key":"R20-16-20210227","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ajh.20379","article-title":"Gemcitabine-induced radiation recall dermatitis in a patient with resistant Hodgkin lymphoma.","volume":"80","author":"Marisavljevic","year":"2005","journal-title":"Am J Hematol"},{"key":"R21-16-20210227","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.lungcan.2006.06.021","article-title":"Unsuccessful rechallenge with pemetrexed after a previous radiation recall dermatitis.","volume":"54","author":"Barlesi","year":"2006","journal-title":"Lung Cancer"},{"key":"R22-16-20210227","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3816\/CLM.2006.n.039","article-title":"Phase II evaluation of gemcitabine monotherapy for cutaneous T-cell lymphoma.","volume":"7","author":"Duvic","year":"2006","journal-title":"Clin Lymphoma Myeloma"},{"key":"R23-16-20210227","first-page":"306","article-title":"Gemcitabine-induced rectus abdominus radiation recall.","volume":"7","author":"Fakih","year":"2006","journal-title":"JOP"},{"key":"R24-16-20210227","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.clon.2005.07.012","article-title":"Gemcitabine-induced radiation necrosis of the pectoralis major muscle.","volume":"18","author":"Horan","year":"2006","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"R25-16-20210227","first-page":"1891","article-title":"Myositis as a radiation-recall phenomenon following palliative chemotherapy with carboplatin-gemcitabin for non-small-cell pulmonary carcinoma.","volume":"150","author":"Pinson","year":"2006","journal-title":"Ned Tijdschr Geneeskd"},{"key":"R26-16-20210227","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/01.cad.0000181590.85476.e3","article-title":"Gemcitabine-related radiation recall in a patient with pancreatic cancer.","volume":"17","author":"Saif","year":"2006","journal-title":"Anticancer Drugs"},{"key":"R27-16-20210227","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/01.coc.0000182426.43595.25","article-title":"An unusual case of gemcitabine-induced radiation recall.","volume":"29","author":"Squire","year":"2006","journal-title":"Am J Clin Oncol"},{"key":"R28-16-20210227","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00066-007-1688-z","article-title":"Radiation recall pneumonitis induced by gemcitabine.","volume":"183","author":"Schwarte","year":"2007","journal-title":"Strahlenther Onkol"},{"key":"R29-16-20210227","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3747\/co.2008.201","article-title":"Radiation recall dermatitis: case report and review of the literature.","volume":"15","author":"Hird","year":"2008","journal-title":"Curr Oncol"},{"key":"R30-16-20210227","first-page":"249","article-title":"Gemcitabine induced radiation recall myositis: report of two cases.","volume":"19","author":"Alco","year":"2009","journal-title":"Uhod-Uluslar Hematol"},{"key":"R31-16-20210227","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1743-7563.2009.01187.x","article-title":"Gemcitabine-induced radiation recall in the treatment of pancreatic cancer.","volume":"5","author":"Zainon","year":"2009","journal-title":"Asia Pac J Clin Oncol"},{"key":"R32-16-20210227","first-page":"18","article-title":"Frequency of radiation recall dermatitis in adult cancer patients.","volume":"28","author":"Kodym","year":"2005","journal-title":"Onkologie"},{"key":"R33-16-20210227","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.ijrobp.2008.02.070","article-title":"Timing of chemotherapy after mammosite radiation therapy system breast brachytherapy: analysis of the american society of breast surgeons mammosite breast brachytherapy registry trial.","volume":"72","author":"Haffty","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R34-16-20210227","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00280-006-0223-8","article-title":"Radiation recall phenomenon secondary to capecitabine: possible role of thymidine phosphorylase.","volume":"58","author":"Saif","year":"2006","journal-title":"Cancer Chemother Pharmacol"},{"key":"R35-16-20210227","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2165\/00128071-200001020-00006","article-title":"Radiation-recall skin disorders associated with the use of antineoplastic drugs. Pathogenesis, prevalence, and management.","volume":"1","author":"Yeo","year":"2000","journal-title":"Am J Clin Dermatol"},{"key":"R36-16-20210227","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.ijrobp.2006.05.073","article-title":"Frequency and characteristics of docetaxel-induced radiation recall phenomenon.","volume":"66","author":"Mizumoto","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R37-16-20210227","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0167-8140(01)00328-0","article-title":"Characterizing the phenomenon of radiation recall dermatitis.","volume":"59","author":"Camidge","year":"2001","journal-title":"Radiother Oncol"},{"key":"R39-16-20210227","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ctrv.2005.07.008","article-title":"Radiation recall: a well recognized but neglected phenomenon.","volume":"31","author":"Azria","year":"2005","journal-title":"Cancer Treat Rev"},{"key":"R40-16-20210227","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00001813-200001000-00003","article-title":"Time- and dose-limiting erysipeloid rash confined to areas of lymphedema following treatment with gemcitabinea report of three cases.","volume":"11","author":"Brandes","year":"2000","journal-title":"Anticancer Drugs"},{"key":"R41-16-20210227","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1468-3083.2002.00485.x","article-title":"Gemcitabine-induced erysipeloid skin lesions in a patient with malignant mesothelioma.","volume":"16","author":"Kuku","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R42-16-20210227","doi-asserted-by":"crossref","first-page":"7224","DOI":"10.1200\/JCO.2005.09.092","article-title":"Double diagnosis in cancer patients and cutaneous reaction related to gemcitabine: case 3. Photo therapy recall with gemcitabine following ultraviolet B treatment.","volume":"23","author":"Badger","year":"2005","journal-title":"J Clin Oncol"},{"key":"R43-16-20210227","first-page":"117","article-title":"Management of stage IIB osteogenic sarcoma: experience at the university of california los angeles.","volume":"3","author":"Eckardt","year":"1985","journal-title":"Cancer Treat Symp"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0b013e31827e4c28","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:14:11Z","timestamp":1620965651000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201303000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0b013e31827e4c28","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}